This finding was consistent with that of McWilliams et al., who also reported a modest enhanced risk of pancreatic cancer diagnosed at an earlier age in patients whose tumors carried CFTR mutations [22]. This evidence concerns the gene CFTR and familial pancreatic carcinoma.